Zota Health Care Limited (NSE:ZOTA)

Market Cap	30.50B
Revenue (ttm)	2.45B
Net Income (ttm)	-504.26M
Shares Out	25.16M
EPS (ttm)	-18.91
PE Ratio	n/a
Forward PE	n/a
Dividend	1.00 (0.08%)
Ex-Dividend Date	Sep 20, 2024

Volume	35,513
Average Volume	106,268
Open	1,216.60
Previous Close	1,212.10
Day's Range	1,191.20 - 1,231.30
52-Week Range	535.00 - 1,305.00
Beta	0.37
RSI	58.51
Earnings Date	Aug 13, 2025

About Theseus Pharmaceuticals

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, wellness, over-the-counter products, ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, heart disease, and thyroid disorders. It operates its retail stores under the DAVAINDIA name. The company also exports its products. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 445
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ZOTA

Financial Performance

In 2023, Zota Health Care's revenue was 1.80 billion, an increase of 28.23% compared to the previous year's 1.41 billion. Losses were -143.48 million, 148.5% more than in 2022.